TrialThe New England journal of medicine2022

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.

Karen J Hager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.